Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -3.89% and Operating profit at -33.23% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1,613.44% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -3.89% and Operating profit at -33.23% over the last 5 years
3
The company has declared Negative results for the last 10 consecutive quarters
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,422 Million (Micro Cap)
75.00
NA
0.24%
-0.53
2.69%
1.85
Revenue and Profits:
Net Sales:
101 Million
(Quarterly Results - Mar 2026)
Net Profit:
8 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
228.41%
0%
228.41%
6 Months
219.62%
0%
219.62%
1 Year
331.61%
0%
331.61%
2 Years
218.73%
0%
218.73%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-3.89%
EBIT Growth (5y)
-32.91%
EBIT to Interest (avg)
45.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.63
Tax Ratio
15.97%
Dividend Payout Ratio
71.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1,594.95%
ROE (avg)
1,613.44%
Valuation key factors
Factor
Value
P/E Ratio
75
Industry P/E
Price to Book Value
2.01
EV to EBIT
71.02
EV to EBITDA
25.31
EV to Capital Employed
3.15
EV to Sales
2.51
PEG Ratio
NA
Dividend Yield
0.22%
ROCE (Latest)
4.44%
ROE (Latest)
2.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
100.60
104.10
-3.36%
Operating Profit (PBDIT) excl Other Income
6.00
13.60
-55.88%
Interest
0.00
0.00
Exceptional Items
0.10
-1.00
110.00%
Consolidate Net Profit
8.10
5.60
44.64%
Operating Profit Margin (Excl OI)
59.20%
35.80%
2.34%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -3.36% vs 15.67% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 44.64% vs -43.43% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
456.50
476.10
-4.12%
Operating Profit (PBDIT) excl Other Income
54.30
69.10
-21.42%
Interest
0.60
0.50
20.00%
Exceptional Items
-1.40
0.90
-255.56%
Consolidate Net Profit
18.90
40.00
-52.75%
Operating Profit Margin (Excl OI)
33.70%
63.60%
-2.99%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -4.12% vs -10.66% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -52.75% vs -33.67% in Dec 2024
About Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. 
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






